DealsVSS Capital invests in Eximia Research NetworkEximia is a multi-therapeutic, clinical trial research company.ByIrien Joseph4 October 2023•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs